FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1927173856> ?p ?o ?g. }

• W1927173856 endingPage "2197" @default.
• W1927173856 startingPage "2197" @default.
• W1927173856 abstract "Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy Ha Na Woo1*, Hye Kyung Chung2*, Eun Jin Ju1, Joohee Jung1,3, Hye-Won Kang4, Sa-Won Lee4, Min-Hyo Seo4, Jin Seong Lee5, Jung Shin Lee1,6, Heon Joo Park7, Si Yeol Song1,8, Seong-Yun Jeong1, Eun Kyung Choi1,2,81Institute for Innovative Cancer Research, 2Center for Development and Commercialization of Anti-cancer Therapeutics, Asan Medical Center, Seoul, 3College of Pharmacy, Duksung Women&#39;s University, Seoul, 4Department of Parenteral Delivery Program, Samyang Pharmaceuticals R&D, Daejeon, 5Department of Radiology and Research Institute of Radiology, 6Department of Internal Medicine, Asan Medical Center, Seoul, 7Department of Microbiology, College of Medicine, Inha University, Inchon, 8Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea*These authors contributed equally to this studyAbstract: Nanoparticles are useful delivery vehicles for promising drug candidates that face obstacles for clinical applicability. Sirolimus, an inhibitor of mammalian target of rapamycin has gained attention for targeted anticancer therapy, but its clinical application has been limited by its poor solubility. This study was designed to enhance the feasibility of sirolimus for human cancer treatment. Polymeric nanoparticle (PNP)–sirolimus was developed as an injectable formulation and has been characterized by transmission electron microscopy and dynamic light scattering. Pharmacokinetic analysis revealed that PNP–sirolimus has prolonged circulation in the blood. In addition, PNP–sirolimus preserved the in vitro killing effect of free sirolimus against cancer cells, and intravenous administration displayed its potent in vivo anticancer efficacy in xenograft tumor mice. In addition, PNP–sirolimus enhanced the radiotherapeutic efficacy of sirolimus both in vitro and in vivo. Clinical application of PNP–sirolimus is a promising strategy for human cancer treatment.Keywords: sirolimus, polymeric nanoparticle, anticancer, radiotherapy" @default.
• W1927173856 created "2016-06-24" @default.
• W1927173856 creator A5000363855 @default.
• W1927173856 creator A5013175108 @default.
• W1927173856 creator A5018860908 @default.
• W1927173856 creator A5022678399 @default.
• W1927173856 creator A5023313081 @default.
• W1927173856 creator A5025995653 @default.
• W1927173856 creator A5035935608 @default.
• W1927173856 creator A5045828791 @default.
• W1927173856 creator A5046815714 @default.
• W1927173856 creator A5084014218 @default.
• W1927173856 creator A5084662421 @default.
• W1927173856 creator A5086510739 @default.
• W1927173856 creator A5091011842 @default.
• W1927173856 date "2012-04-01" @default.
• W1927173856 modified "2023-10-10" @default.
• W1927173856 title "Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy" @default.
• W1927173856 cites W1969080040 @default.
• W1927173856 cites W1989195046 @default.
• W1927173856 cites W1989353157 @default.
• W1927173856 cites W1994423628 @default.
• W1927173856 cites W1996811911 @default.
• W1927173856 cites W1997714593 @default.
• W1927173856 cites W2008825756 @default.
• W1927173856 cites W2008932991 @default.
• W1927173856 cites W2009805582 @default.
• W1927173856 cites W2012867962 @default.
• W1927173856 cites W2013470095 @default.
• W1927173856 cites W2022822608 @default.
• W1927173856 cites W2023771705 @default.
• W1927173856 cites W2025184018 @default.
• W1927173856 cites W2026351725 @default.
• W1927173856 cites W2032760352 @default.
• W1927173856 cites W2032860131 @default.
• W1927173856 cites W2049035021 @default.
• W1927173856 cites W2052460475 @default.
• W1927173856 cites W2060157525 @default.
• W1927173856 cites W2063717106 @default.
• W1927173856 cites W2068149733 @default.
• W1927173856 cites W2074153710 @default.
• W1927173856 cites W2080100938 @default.
• W1927173856 cites W2088787531 @default.
• W1927173856 cites W2093216555 @default.
• W1927173856 cites W2102148658 @default.
• W1927173856 cites W2117446564 @default.
• W1927173856 cites W2132834292 @default.
• W1927173856 cites W2136907822 @default.
• W1927173856 cites W2143393758 @default.
• W1927173856 cites W2147394591 @default.
• W1927173856 cites W2151576707 @default.
• W1927173856 cites W2414855678 @default.
• W1927173856 doi "https://doi.org/10.2147/ijn.s29480" @default.
• W1927173856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3356221" @default.
• W1927173856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22619555" @default.
• W1927173856 hasPublicationYear "2012" @default.
• W1927173856 type Work @default.
• W1927173856 sameAs 1927173856 @default.
• W1927173856 citedByCount "17" @default.
• W1927173856 countsByYear W19271738562012 @default.
• W1927173856 countsByYear W19271738562013 @default.
• W1927173856 countsByYear W19271738562014 @default.
• W1927173856 countsByYear W19271738562015 @default.
• W1927173856 countsByYear W19271738562016 @default.
• W1927173856 countsByYear W19271738562017 @default.
• W1927173856 countsByYear W19271738562018 @default.
• W1927173856 countsByYear W19271738562019 @default.
• W1927173856 countsByYear W19271738562020 @default.
• W1927173856 countsByYear W19271738562021 @default.
• W1927173856 countsByYear W19271738562022 @default.
• W1927173856 countsByYear W19271738562023 @default.
• W1927173856 crossrefType "journal-article" @default.
• W1927173856 hasAuthorship W1927173856A5000363855 @default.
• W1927173856 hasAuthorship W1927173856A5013175108 @default.
• W1927173856 hasAuthorship W1927173856A5018860908 @default.
• W1927173856 hasAuthorship W1927173856A5022678399 @default.
• W1927173856 hasAuthorship W1927173856A5023313081 @default.
• W1927173856 hasAuthorship W1927173856A5025995653 @default.
• W1927173856 hasAuthorship W1927173856A5035935608 @default.
• W1927173856 hasAuthorship W1927173856A5045828791 @default.
• W1927173856 hasAuthorship W1927173856A5046815714 @default.
• W1927173856 hasAuthorship W1927173856A5084014218 @default.
• W1927173856 hasAuthorship W1927173856A5084662421 @default.
• W1927173856 hasAuthorship W1927173856A5086510739 @default.
• W1927173856 hasAuthorship W1927173856A5091011842 @default.
• W1927173856 hasBestOaLocation W19271738561 @default.
• W1927173856 hasConcept C121608353 @default.
• W1927173856 hasConcept C126322002 @default.
• W1927173856 hasConcept C143998085 @default.
• W1927173856 hasConcept C150903083 @default.
• W1927173856 hasConcept C171250308 @default.
• W1927173856 hasConcept C192562407 @default.
• W1927173856 hasConcept C207001950 @default.
• W1927173856 hasConcept C2777921159 @default.
• W1927173856 hasConcept C2779820397 @default.
• W1927173856 hasConcept C71924100 @default.
• W1927173856 hasConcept C86803240 @default.
• W1927173856 hasConcept C98274493 @default.

• next